Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer

Clinical trial NCT00004890 · COMPLETED

Trial details

NCT number: NCT00004890
Sponsor: BioMedicines
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Extravasation Kidney Cancer

Start date: 2000-12-01
Primary completion: 2002-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.